Hot Topics in Diabetic Kidney Disease

Friday, May 10, 2024

3:30 PM - 4:30 PM CDT

Location: Celestin E, Level 3

CE: 1

Learning Objectives:

Identify tools, including biomarkers and risk stratification models, in the early detection and risk stratification for diabetic kidney disease.
Review renal protective therapies including those with evidence in patients with Type 1 Diabetes, recently approved medications and ongoing clinical studies on medications for the management of diabetic kidney disease.
Review personalized strategies for glycemic management in patients with DM and advanced CKD, focusing on the use of technology.

Yael Tobi Harris, MD, PhD (she/her/hers)

Chief, Division of Endocrinology, Diabetes and Metabolism
Zucker School of Medicine at Hofstra/Northwell
Great Neck, New York, United States